Provided by Tiger Trade Technology Pte. Ltd.

Beam Therapeutics, Inc.

24.20
-0.9800-3.89%
Volume:424.86K
Turnover:10.34M
Market Cap:2.50B
PE:-28.89
High:24.89
Open:24.78
Low:23.98
Close:25.18
52wk High:38.26
52wk Low:19.57
Shares:103.29M
Float Shares:91.60M
Volume Ratio:2.95
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8376
EPS(LYR):-0.8100
ROE:-8.18%
ROA:-17.01%
PB:2.34
PE(LYR):-29.87

Loading ...

Beam Therapeutics presents Phase 1/2 BEAM-302 AATD trial data at ATS 2026

Reuters
·
May 19

Analysts Conflicted on These Healthcare Names: Omnicell (OMCL), Beam Therapeutics (BEAM) and Zentalis Pharmaceuticals (ZNTL)

TIPRANKS
·
May 13

Beam Therapeutics to present updated BEACON trial biomarker data for risto-cel in SCD at EHA2026

Reuters
·
May 12

Will Beam Therapeutics' (BEAM) Revenue Surge, Pipeline Updates and Added Liquidity Change Its Narrative?

Simply Wall St.
·
May 11

Evercore ISI Sticks to Their Buy Rating for Beam Therapeutics (BEAM)

TIPRANKS
·
May 09

Beam Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
May 07

Beam Therapeutics Q1 net loss narrows beating analyst estimates

Reuters
·
May 07

Beam Q1 FY26 net loss narrows 12.94% to $94.3 million

Reuters
·
May 07

Beam Therapeutics Q1 Operating Expenses USD 138.953 Million

THOMSON REUTERS
·
May 07

Beam Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates

GlobeNewswire
·
May 07

A Look At Beam Therapeutics (BEAM) Valuation After TIME Recognition And BEACON Trial Progress

Simply Wall St.
·
May 03

Beam Therapeutics announces annual shareholder meeting via webcast

Reuters
·
Apr 18

JonesTrading Sticks to Its Buy Rating for Beam Therapeutics (BEAM)

TIPRANKS
·
Apr 07

Why Beam Therapeutics (BEAM) Is Up 12.6% After NEJM Base-Editing Sickle Cell Data Publication

Simply Wall St.
·
Apr 06

Beam Therapeutics CEO John M. Evans disposes of $1.1 million common shares

Reuters
·
Apr 02

Beam Therapeutics’ risto-cel shows efficacy in Sickle Cell Disease trial

TIPRANKS
·
Apr 02

Beam risto-cel BEACON trial data in NEJM support BLA filing by late 2026

Reuters
·
Apr 02

Beam Therapeutics (BEAM) Gets a Buy from Wedbush

TIPRANKS
·
Mar 28

Beam Therapeutics (BEAM) Gets a Buy from Bernstein

TIPRANKS
·
Mar 26

BUZZ-U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKings

Reuters
·
Mar 26